{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:28:47Z","timestamp":1790659727848,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"name":", Labor and Welfare"},{"name":"Japan Foundation for Neuroscience and Mental Health"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jad.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T01:03:47Z","timestamp":1551747827000},"page":"108-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Predicting relapse in major depression after successful initial pharmacological treatment"],"prefix":"10.1016","volume":"250","author":[{"given":"Tatsuo","family":"Akechi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Mantani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7936-260X","authenticated-orcid":false,"given":"Ken'ichi","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5649-2310","authenticated-orcid":false,"given":"Mitsuhiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-8649","authenticated-orcid":false,"given":"Masatoshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.jad.2019.03.004_bib0001","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder, third edition","volume":"167","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.03.004_bib0002","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/15622975.2013.804195","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders","volume":"14","author":"Bauer","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.03.004_bib0003","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/15622975.2014.1001786","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015","volume":"16","author":"Bauer","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.03.004_bib0004","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1176\/appi.ajp.2008.07121882","article-title":"Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study","volume":"165","author":"Cho","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.03.004_bib0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.03.004_bib0006","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1503\/cmaj.110676","article-title":"Predictors of long-term prognosis of depression","volume":"183","author":"Colman","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.jad.2019.03.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002542","article-title":"Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis","volume":"3","author":"Cuijpers","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2019.03.004_bib0008","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpsychores.2009.05.003","article-title":"Assessment of mood: guides for clinicians","volume":"68","author":"Furukawa","year":"2010","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jad.2019.03.004_bib0009","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1745-6215-12-116","article-title":"Strategic Use of New generation antidepressants for Depression: SUN(^_^)D study protocol","volume":"12","author":"Furukawa","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.jad.2019.03.004_bib0010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2019.03.004_bib0011","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-0447.2009.01519.x","article-title":"Prevalence and predictors of recurrence of major depressive disorder in the adult population","volume":"122","author":"Hardeveld","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2019.03.004_bib0012","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1037\/a0027665","article-title":"Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder","volume":"80","author":"Harkness","year":"2012","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2019.03.004_bib0013","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jad.2013.07.023","article-title":"Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS)","volume":"151","author":"Jang","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.03.004_bib0014","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/S0033291703007827","article-title":"Time to recurrence after recovery from major depressive episodes and its predictors","volume":"33","author":"Kanai","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2019.03.004_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12916-018-1096-5","article-title":"Optimising first- and second-line treatment strategies for untreated major depressive disorder - the SUND study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial","volume":"16","author":"Kato","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.jad.2019.03.004_bib0016","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0165-1781(03)00239-7","article-title":"Lifetime and 6-month prevalence of DSM-III-R psychiatric disorders in an urban community in Japan","volume":"121","author":"Kawakami","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2019.03.004_bib0017","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: section 3. Pharmacological Treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can. J. Psychiatry Revue canadienne de psychiatrie"},{"key":"10.1016\/j.jad.2019.03.004_bib0018","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2019.03.004_bib0019","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jad.2019.03.004_bib0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/ajp.149.6.795","article-title":"Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study","volume":"149","author":"Maj","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.03.004_bib0021","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4088\/JCP.v65n0612","article-title":"Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder","volume":"65","author":"Melartin","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.03.004_bib0022","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1176\/ajp.156.7.1000","article-title":"Recurrence after recovery from major depressive disorder during 15 years of observational follow-up","volume":"156","author":"Mueller","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.03.004_bib0023","unstructured":"NICE, 2009. last updated April 2016. National institute for health and care excellence depression in adults: recognition and management. clinical guideline."},{"key":"10.1016\/j.jad.2019.03.004_bib0024","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1525-1497.2005.0144.x","article-title":"Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone?","volume":"20","author":"Pinto-Meza","year":"2005","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jad.2019.03.004_bib0025","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1017\/S0033291700033134","article-title":"Remission and relapse in major depression: a two-year prospective follow-up study","volume":"25","author":"Ramana","year":"1995","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2019.03.004_bib0026","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2019.03.004_bib0027","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1745-6215-13-80","article-title":"The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase","volume":"13","author":"Shimodera","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.jad.2019.03.004_bib0028","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2019.03.004_bib0029","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1994.03520220043029","article-title":"Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study","volume":"272","author":"Spitzer","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2019.03.004_bib0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/da.22215","article-title":"Development and validation of a prediction algorithm for use by health professionals in prediction of recurrence of major depression","volume":"31","author":"Wang","year":"2014","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2019.03.004_bib0031","unstructured":"WHO, 2008. The global burden of disease: 2004 update."},{"key":"10.1016\/j.jad.2019.03.004_bib0032","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hup.1033","article-title":"Relapse rates with long-term antidepressant drug therapy: a meta-analysis","volume":"24","author":"Williams","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.03.004_bib0033","series-title":"G-I-N Conference","article-title":"PROBAST-Prediction model risk of bias assessment tool","author":"Wolff","year":"2015"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718317555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718317555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:09:38Z","timestamp":1663027778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718317555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":33,"alternative-id":["S0165032718317555"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.03.004","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting relapse in major depression after successful initial pharmacological treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}